SEC

The company also entered into a sales agreement with Cowen and Company to offer up to $75 million of its common stock for sale.

Qiagen terminated the first project for an NGS-based clinical trial assay after its pharmaceutical partner's phase II drug trial failed to meet its endpoint.

The US Securities and Exchange Commission charged Elizabeth Holmes, the founder and CEO of Theranos, with fraud.

The company issued more than 1.8 million shares of its common stock to several of its trade creditors to erase debt that it owed them, Precipio said in an SEC document.

The deal ends an investigation by the SEC into certain accounting practices by Alere's foreign subsidiaries. The company also consented to a cease-and-desist order. 

The company, which also said it is short on funds, may have to pay $18.3 million to Hudson Bay Master Fund if forebearance is not granted for the default.

Insider Info

A clinical trial PI faces insider-trading charges, according to Pharmalot's Ed Silverman.

The company did not specify the number of shares it will offer or the offering price, but said it intends to trade on the Nasdaq Global Market.

The company previously said in an SEC document that it raised $16.1 million toward a targeted goal of $30 million.

NEW YORK (GenomeWeb) — Bio-Rad Laboratories has resolved a US Securities and Exchange Commission investigation into its violation of the Foreign Corrupt Practices Act due to the company's subsidiaries having made improper payments to foreign officials in Russia, Vietnam, and Thailand in order to

Pages

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.